Alder Biopharmaceuticals Inc. (nasdaq: Aldr) - Employees, Business, Industry & CEO

Alder Biopharmaceuticals Inc. (nasdaq: Aldr) was founded in 2004.

Alder Biopharmaceuticals Inc. (nasdaq: Aldr) headquarters are in Bothell, Washington, United States.

Alder Biopharmaceuticals Inc. (nasdaq: Aldr) has 234 employees.

Alder Biopharmaceuticals Inc. (nasdaq: Aldr) is in biotechnology sector.

Yes, Alder Biopharmaceuticals Inc. (nasdaq: Aldr) is a public company.

Alder's mission is to help alleviate human suffering by generating better and safer antibody therapeutics through novel technologies. alder plays two roles: as a biopharmaceutical company, alder uses its proprietary technologies to uniquely identify, develop, produce and market its own antibody therapeutics. the work being done at alder today will help those who suffer from cancer, autoimmune diseases, and inflammatory diseases. as a licensing partner, alder is revolutionizing the way the pharmaceutical industry discovers, develops and produces antibody therapeutics. through various licensing agreements, alder has used its proprietary technology to help major biopharmaceutical partners advance novel therapeutics to the clinic in less time and at lower cost. alder's licensing strategy also includes identifying strategic partners to assist in the development and marketing of its preclinical and clinical pipeline programs.

We are not able to find any specialities related to Alder Biopharmaceuticals Inc. (nasdaq: Aldr) at the moment.

We do not have the information about the CEO of Alder Biopharmaceuticals Inc. (nasdaq: Aldr). Our systems are trying to find it, we will update it as soon as we have it.